DE69329070D1 - Verfahren zur Reinigung von Beta-Carotin - Google Patents

Verfahren zur Reinigung von Beta-Carotin

Info

Publication number
DE69329070D1
DE69329070D1 DE69329070T DE69329070T DE69329070D1 DE 69329070 D1 DE69329070 D1 DE 69329070D1 DE 69329070 T DE69329070 T DE 69329070T DE 69329070 T DE69329070 T DE 69329070T DE 69329070 D1 DE69329070 D1 DE 69329070D1
Authority
DE
Germany
Prior art keywords
carotene
beta
compositions
cis
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69329070T
Other languages
English (en)
Inventor
Geoffrey Haigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natural Carotene Corp
Original Assignee
Natural Carotene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Carotene Corp filed Critical Natural Carotene Corp
Application granted granted Critical
Publication of DE69329070D1 publication Critical patent/DE69329070D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69329070T 1992-10-27 1993-10-27 Verfahren zur Reinigung von Beta-Carotin Expired - Lifetime DE69329070D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/967,897 US5310554A (en) 1992-10-27 1992-10-27 High purity beta-carotene
PCT/US1993/010314 WO1994010140A1 (en) 1992-10-27 1993-10-27 High purity beta-carotene

Publications (1)

Publication Number Publication Date
DE69329070D1 true DE69329070D1 (de) 2000-08-24

Family

ID=25513473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329070T Expired - Lifetime DE69329070D1 (de) 1992-10-27 1993-10-27 Verfahren zur Reinigung von Beta-Carotin

Country Status (8)

Country Link
US (1) US5310554A (de)
EP (1) EP0666845B1 (de)
JP (1) JPH09500864A (de)
AT (1) ATE194830T1 (de)
AU (1) AU681868B2 (de)
CA (1) CA2147825A1 (de)
DE (1) DE69329070D1 (de)
WO (1) WO1994010140A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660630B2 (en) * 1990-10-01 1995-07-06 Brigham And Women's Hospital Beta-carotene and vitamin E therapy for inhibition of major vascular events
DE69327100T2 (de) * 1992-06-04 2000-04-13 Betatene Pty Ltd Gemisch mit hohem gehalt an cis beta-carotin
JPH07242621A (ja) * 1994-03-02 1995-09-19 Nippon Oil Co Ltd カロチノイド化合物の抽出方法
US5475006A (en) * 1994-08-10 1995-12-12 National Research Council Of Canada Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-differentiation inducers, anti-proliferative agents, and anti-tumor agents
US7132458B2 (en) 1994-08-10 2006-11-07 Chemaphor Inc. Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
DE4429506B4 (de) * 1994-08-19 2007-09-13 Degussa Gmbh Verfahren zur Extraktion natürlicher Carotinoid-Farbstoffe
DE19517422A1 (de) * 1995-05-12 1996-11-14 Basf Ag Verfahren zur Herstellung von beta-Carotin-Präparaten mit hohem 9(Z)-Gehalt
EP0844873B1 (de) * 1995-08-14 2005-03-02 Optigenex, Inc. Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
DE19531254A1 (de) * 1995-08-25 1997-02-27 Sueddeutsche Kalkstickstoff Verfahren zur Extraktion von Carotinfarbstoffen aus festen Naturstoffen
HUT75371A (en) * 1995-10-09 1997-05-28 Motiv Magyar Nemet Kereskedelm Natural carotene-concentrate of vegetable material and process for producing of that
US6133318A (en) 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions
US6133317A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
US5576349A (en) * 1995-11-30 1996-11-19 The General Hospital Corporation Retionoic acid treatment of cardiac arrhythmia
IL119224A (en) * 1996-09-09 2002-11-10 Hadasit Med Res Service Medicament for protection from effects of irradiation
DE19638004A1 (de) * 1996-09-18 1998-03-19 Sueddeutsche Kalkstickstoff Verfahren zur Gewinnung von Carotinextrakten mit einem weitgehend unveränderten all-trans-Isomerenanteil aus Naturstoffen
US5776349A (en) * 1996-12-20 1998-07-07 Eastman Chemical Company Method for dewatering microalgae with a jameson cell
US5910254A (en) * 1996-12-20 1999-06-08 Eastman Chemical Company Method for dewatering microalgae with a bubble column
US5951875A (en) * 1996-12-20 1999-09-14 Eastman Chemical Company Adsorptive bubble separation methods and systems for dewatering suspensions of microalgae and extracting components therefrom
US6000551A (en) * 1996-12-20 1999-12-14 Eastman Chemical Company Method for rupturing microalgae cells
US20020082459A1 (en) * 1997-05-28 2002-06-27 Bailey David T. High purity beta-carotene and process for obtaining same
JPH11187894A (ja) * 1997-12-26 1999-07-13 Oyo Seikagaku Kenkyusho 高純度 ９−シス−β−カロチン含有組成物及びその製法
US6309677B1 (en) * 1998-03-24 2001-10-30 Amway Corporation Multi-carotenoid product
IL126076A (en) * 1998-09-04 2005-05-17 Ibr Ltd Transparent composition comprising phytoene and phytofluene
FR2782921B1 (fr) * 1998-09-09 2002-09-20 Dior Christian Parfums Extrait lipidique de l'algue skeletonema, procede de preparation et utilisation dans des domaines cosmetique et pharmaceutique, notamment dermatologique
US6660320B1 (en) * 1999-06-25 2003-12-09 University Of Saskatchewan Technologies Inc. Process for producing an antioxidant extract from the bearberry plant
GB2358862B (en) * 1999-12-21 2004-07-21 Fermentron Ltd Processes for Extracting Carotenoids from Biomass Carotenoid Sources
EP1250322A1 (de) * 2000-01-27 2002-10-23 Dsm N.V. Isolierung von carotenoiden kristallen
US6852905B2 (en) 2001-11-15 2005-02-08 Paragon Trade Brands, Inc. Fluid handling layers made from foam and absorbent articles containing same
EP1361280A1 (de) * 2002-05-08 2003-11-12 Wageningen University Verfahren zur kontinuierlichen Produktion und Extraktion von Carotinoiden aus natürlichen Quellen
JP2004038515A (ja) * 2002-07-03 2004-02-05 Sanyo Electric Co Ltd データ記録装置
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
CA2495167C (en) * 2002-07-29 2018-08-21 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20040126338A1 (en) * 2002-12-30 2004-07-01 Rod Ausich Process of converting trans-lutein into cis-lutein and the uses thereof
US7074990B2 (en) * 2003-06-27 2006-07-11 Agricultural Research Organization, The Volcani Center Carotenoids rich paprika cultivars
JP4526244B2 (ja) 2003-06-30 2010-08-18 ブラザー工業株式会社 インクジェットヘッド及びインクジェットプリンタ並びにインクジェットヘッドの製造方法
JP5559453B2 (ja) * 2004-02-10 2014-07-23 ネステク ソシエテ アノニム カロテノイド化合物のシス異性体を含む組成物及び方法
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2581507C (en) 2004-09-28 2013-09-10 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
US7247752B2 (en) 2004-10-01 2007-07-24 Cardax Pharmaceuticals, Inc. Methods for the synthesis of astaxanthin
ES2546484T3 (es) 2005-03-18 2015-09-24 Dsm Ip Assets B.V. Producción de carotenoides en levadura y hongos oleaginosos
AU2007283096B2 (en) * 2006-08-08 2014-03-20 Société des Produits Nestlé S.A. Stable and bioavailable compositions of isomers of carotenoids for skin and hair
WO2008042338A2 (en) 2006-09-28 2008-04-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
DK2214656T3 (en) * 2007-10-26 2019-03-25 Avivagen Inc COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE
JP5733592B2 (ja) * 2008-10-20 2015-06-10 株式会社日健総本社 脂質異常治療薬の副作用防止物質
US20100166677A1 (en) 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
US20110165662A1 (en) * 2009-07-13 2011-07-07 Inventure Chemical, Inc. Method for harvesting microalgae suspended in an aqueous solution using a hydrophobic chemical
WO2011019668A1 (en) * 2009-08-09 2011-02-17 Meltology, Llc Topical cosmeceutical formulation and methods of making and using same
US8771758B2 (en) * 2010-06-30 2014-07-08 Avon Products, Inc. Use of Tiliacora triandra in cosmetics and compositions thereof
WO2016076454A1 (ko) * 2014-11-10 2016-05-19 한국생명공학연구원 미생물의 배양방법 및 그 배양미생물로부터 9-시스 베타카로틴의 분리 및 정제방법
CN106278978A (zh) * 2016-08-09 2017-01-04 嘉必优生物技术（武汉）股份有限公司 制备β‑胡萝卜素晶体的方法
CN106278977A (zh) * 2016-08-09 2017-01-04 嘉必优生物技术（武汉）股份有限公司 制备β‑胡萝卜素晶体的方法
CN116268424A (zh) * 2016-11-17 2023-06-23 德布勒森大学 提供维生素a5途径的维甲类的前体化合物及其用途
CN109503448B (zh) * 2018-12-28 2021-02-26 晨光生物科技集团股份有限公司 从盐藻中提取制备高含量β-胡萝卜素的工业化方法
WO2021191929A1 (en) * 2020-03-24 2021-09-30 Chitra Vasant Savangikar Oil rich in beta-carotene
GB202114072D0 (en) * 2021-10-01 2021-11-17 Givaudan Sa Method
CN114890929B (zh) * 2022-04-11 2024-02-02 万华化学集团股份有限公司 一种β-胡萝卜素固体除磷纯化的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039877A (en) * 1961-03-02 1962-06-19 Nopco Chem Co Stabilized carotene compositions
US3492202A (en) * 1967-12-12 1970-01-27 Pfizer & Co C Process for the production of beta-carotene
US4199895A (en) * 1977-05-25 1980-04-29 Yeda Research And Development Co. Ltd. Production of glycerol, carotenes and algae meal
EP0052777A1 (de) * 1980-11-20 1982-06-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Extraktion von beta-Carotin aus Algen
US4713398A (en) * 1985-08-30 1987-12-15 Microbio Resources, Inc. Naturally-derived carotene/oil composition
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
US4851339A (en) * 1986-04-01 1989-07-25 Hills Christopher B Extraction of anti-mutagenic pigments from algae and vegetables
US5019668A (en) * 1988-06-14 1991-05-28 Palm Oil Research & Development Board Recovery of carotenoids
JPH02117655A (ja) * 1988-10-26 1990-05-02 Nishi Nippon Jiyoukasou Kanri Center:Kk ホテイアオイカロチン
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
AU2899092A (en) * 1990-05-18 1994-05-09 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
AU664104B2 (en) * 1992-06-04 1995-11-02 Cognis Australia Pty Ltd High CIS beta-carotene composition

Also Published As

Publication number Publication date
EP0666845B1 (de) 2000-07-19
JPH09500864A (ja) 1997-01-28
CA2147825A1 (en) 1994-05-11
ATE194830T1 (de) 2000-08-15
EP0666845A1 (de) 1995-08-16
AU5453094A (en) 1994-05-24
US5310554A (en) 1994-05-10
WO1994010140A1 (en) 1994-05-11
AU681868B2 (en) 1997-09-11

Similar Documents

Publication Publication Date Title
DE69329070D1 (de) Verfahren zur Reinigung von Beta-Carotin
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
DE69936484D1 (de) Verfahren zur Verwendung von Zusammensetzungen von konjugierter Linolsäure die mit Isomeren angereichert sind
DE59209907D1 (de) Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE59309043D1 (de) Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und diese enthaltenden pharmazeutischen Präparaten
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
DE3862337D1 (de) Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten.
SE8901041D0 (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
DE69302883T2 (de) L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
PT91852A (pt) Processo para a preparacao de produtos contendo psyllium
ATE177950T1 (de) Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
DE69209505T2 (de) Lipoaminosauren,ihre herstellung und verwendung
BG105275A (en) Tan-1057 derivatives
DE69507150T2 (de) Gelbildende präparate, die optisch angereicherte gelbildner enthalten
HUT67137A (en) Substituted mendelic acid derivatives. process for their production and pharmaceutical compositions comprising them
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
NZ268476A (en) 14-substituted marcfortines, preparation and pharmaceutical compositions thereof
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
HUP9802314A2 (hu) Zeaxantin tiszta 3R-3'R sztereoizomerje makuláris degeneráció emberben való kezelésére
ATE141614T1 (de) Neue peptidderivate im prozess von zelladhäsion wirksam, verfahren zur deren herstellung und pharmazeutische zusammensetzungen die sie enthalten

Legal Events

Date Code Title Description
8332 No legal effect for de